0
March 3, 1993, Vol 269, No. 9 >
ARTICLE | March 3, 1993

Preventive Health Care for Adults With HIV Infection FREE

John F. Jewett, MD, MPH; Frederick M. Hecht, MD
[+] Author Affiliations

Reprint requests to DGIM-SFGH, University of California, San Francisco, Box 0862, Third and Parnassus Avenues, San Francisco, CA 94143-0862 (Dr Hecht).


JAMA. 1993;269(9):1144-1153. doi:10.1001/jama.1993.03500090080037
Text Size: A A A
Published online
Article
References

Objective.  —To assess the level of evidence for preventive health interventions for adults with human immunodeficiency virus (HIV) infection.

Data Sources.  —A MEDLINE literature search for each intervention, supplemented by reviewing conference proceedings and the recommendations of experts.

Study Selection.  —English-language studies of interventions that contribute to one of the following goals were reviewed: (1) prevention of complications of HIV infection; (2) early detection of complications, before symptoms develop, at a stage in which early treatment could lead to improved outcome; (3) slowing of HIV disease progression; (4) reduction in the risk of transmission of infectious agents, such as HIV itself; and (5) prevention of psychological distress and improvement in the quality of life.

Data Extraction.  —The importance of interventions and quality of supporting evidence were evaluated using criteria modified from the US Preventive Services Task Force.

Data Synthesis.  —Existing evidence strongly supports the efficacy of some preventive measures: primary and secondary Pneumocystis carinii pneumonia prophylaxis; secondary prophylaxis of Cryptococcus, Toxoplasma, and cytomegalovirus infections; tuberculin testing, with chemotherapy for individuals with positive test results; syphilis screening; Papanicolaou tests; educational measures to reduce the transmission of HIV and other infections; T-lymphocyte monitoring; and antiretroviral therapy in selected patients. Recommended measures of possible, but less certain, effectiveness include vaccines to prevent influenza, Haemophilus influenzae, pneumococcal, and hepatitis B infections; prophylaxis for recurrent esophageal and vaginal candidiasis; primary prophylaxis of Mycobacterium avium complex; tuberculosis prophylaxis for anergic, high-risk individuals; routine physical examination; screening for gonorrhea and Chlamydia in high-risk women; monitoring Toxoplasma titers, complete blood cell counts, and serum chemistry values; attempting to maintain weight through nutritional interventions; and exercise. Mental health and substance abuse interventions are probably very important, but documentation of their benefits is limited. Some measures require further study before they can routinely be recommended, including vitamin and mineral supplementation; specific nutritional diets; and laboratory tests, other than CD4 counts, for monitoring disease progression.

Conclusions.  —Persons with HIV infection have different stage-specific health maintenance needs that form an important part of comprehensive care for people in all stages of infection.(JAMA. 1993;269:1144-1153)

REFERENCES

1 +
Lemp GF, Payne SF, Neal D, et al.  Survival trends for patients with AIDS. JAMA . 1990;;263: 402-406.
2 +
Harris JE.  Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984-1987. JAMA . 1990;;263:397-401.
3 +
Centers for Disease Control.  Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR . 1987;;36( (suppl 1S) ):1S-15S.
4 +
Stein DS, Korvick JA, Vermund SH.  CD4 lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis . 1992;;165:352-363.
5 +
Taylor JMG, Fahey JL, Detels R, et al.  CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr . 1989;;2:114-124.
6 +
Burcham J, Marmor M, Dubin N, et al.  CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS . 1991;;5:365-372.
7 +
Centers for Disease Control.  Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. MMWR . 1992;;41( (RR-8) ):1-16.
8 +
Malone JL, Simms TE, Gray GC, et al.  Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patents: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr . 1990;;3:144-151.
9 +
Hoover DR, Graham HMH, Chen B, et al.  Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr . 1992;;5:794-802.
10 +
Munoz A, Vlahov D, Solomon L, et al.  Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr . 1992;;5:694-700.
11 +
Moss AR, Bacchetti P, Osmond D, et al.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. BMJ . 1988;;296:745-750.
12 +
Fahey JL, Taylor JMG, Detal R, et al.  The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1. N Engl J Med . 1990;;322:166-172.
13 +
Anderson RE, Lang W, Shiboski S, et al.  Use of β-2 microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection. Arch Intern Med . 1990;; 150:73-77.
14 +
Hofmann B, Wand Y, Cumberland WG, et al.  Serum beta-2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS . 1990;;4:207-214.
15 +
Lifson AR, Hessol NA, Buchbinder SP, et al.  Serum β2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet . 1992;;339: 1436-1440.
16 +
Melmed RN, Taylor JMG, Detels R, et al.  Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS. J Acquir Immune Defic Syndr . 1989;;2:70-76.
17 +
Kramer A, Wiktor SZ, Fuchs D, et al.  Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection. J Acquir Immune Defic Syndr . 1989;; 2:291-296.
18 +
Zangerle R, Fuchs D, Rebnegger G, et al.  Markers for disease progression in intravenous drug users infected with HIV-1. AIDS . 1991;;5: 985-991.
19 +
Chaisson RE, Taylor E, Margolick JB, et al.  Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr . 1992;;5:456-460.
20 +
Flegg PJ, Brettle RP, Robertson JR, et al.  β2-microglobulin levels in drug users: the influence of risk behavior. AIDS . 1991;;5:1021-1024.
21 +
Pedersen C, Nielsen CM, Vestergaard BF, et al.  Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. BMJ . 1987;;295:567-569.
22 +
Forster SM, Osborne LM, Cheingsong-Popov R, et al.  Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection. AIDS . 1987;;1:235-240.
23 +
Macdonell KB, Chmiel JS, Poggensee L, et al.  Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med . 1990;;89:706-712.
24 +
Phair J, Munoz A, Detels R, et al.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type I. N Engl J Med . 1990;;322:161-165.
25 +
Centers for Disease Control.  Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR . 1992;;41( (RR-4) ):1-11.
26 +
National Institute of Allergy and Infectious Diseases.  Recommendations for zidovudine: early infection. JAMA . 1990;;263:1606, 1609.
27 +
Lang W, Perkins H, Anderson RE, et al.  Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr . 1989;;2:63-69.
28 +
Hardy WD.  Prophylaxis of AIDS-related opportunistic infections (OIs): current status and future strategies.  In: Volberding P, Jacobson MA, eds. Clinical AIDS Review 1991 . New York, NY: Marcel Dekker Inc; 1991;:145-180.
29 +
Freedberg KA, Tosteson ANA, Cotton DJ, Goldman L.  Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effectiveness analysis. J Gen Intern Med . 1992;;7:261-272.
30 +
Polis M, Masur H.  Predicting the progression to AIDS. Am J Med . 1990;;89:701-705.
31 +
US Preventive Services Task Force. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions . Baltimore, Md: Williams & Wilkins; 1989;.
32 +
Brenner M, Ognibene FP, Lack EE, et al.  Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis . 1987;;136:1199-1206.
33 +
Krumholz HM, Sullam PM, Tager IB.  Predictors of mortality in patients with AIDS and Pneumocystis carinii pneumonia (PCP).  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract MBP375.
34 +
Dover JS, Johnson RA.  Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol . 1991;;127(pt 1):1383-1391.
35 +
Dover JS, Johnson RA.  Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol . 1991;;127(pt 2):1549-1558.
36 +
Rosenberg PR, Uliss AE, Friedland GH, et al.  Acquired immunodeficiency syndrome: ophthalmic manifestations in ambulatory patients. Ophthalmology . 1983;;90:874-878.
37 +
Palestine AG, Rodrigues MM, Macher AM, et al.  Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology . 1984;;91:1092-1099.
38 +
Bloom JN, Palestine AG.  The diagnosis of cytomegalovirus retinitis. Ann Intern Med . 1988;;109: 963-969.
39 +
Henderly DE, Freeman WR, Causey, et al.  Cytomegalovirus retinitis and response to therapy with gancyclovir. Ophthalmology . 1987;;94: 425-434.
40 +
Bottles K, McPhaul LW, Volberding P.  Fine-needle aspiration biopsy of patients with the acquired immunodeficiency syndrome (AIDS): experience in an outpatient clinic. Ann Intern Med . 1988;;108:42-45.
41 +
Shapiro AL, Pincus RL.  Fine-needle aspiration of diffuse cervical lymphadenopathy in patients with acquired immunodeficiency syndrome. Otolaryngol Head Neck Surg . 1991;;105:419-421.
42 +
Rhoads JL, Wright DC, Redfield RR, Burke DS.  Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA . 1987;; 257:3105-3107.
43 +
Imam W, Carpenter CJ, Mayer K, et al.  Hierarchical pattern of mucosal candida infection in HIV seropositive women. Am J Med . 1990;;89:142-146.
44 +
Byrne MA, Taylor-Robinson D, Munday PE, Harris JRW.  The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS . 1989;;3:379-382.
45 +
Schrager LK, Friedland GH, Maude D, et al.  Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr . 1989;;2:570-575.
46 +
Schafer A, Friedmann W, Mielke M, et al.  The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol . 1991;;164:593-599.
47 +
Vermund SH, Kelley KF, Klein RS, et al.  High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol . 1991;;165:392-400.
48 +
Matorras R, Ariceta JM, Rementeria A, et al.  Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection. Am J Obstet Gynecol . 1991;;164:42-44.
49 +
Johnson JC, Burnett AF, Willet GD, et al.  High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol . 1992;;79:321-327.
50 +
Maiman M, Fruchter RG, Serur E, et al.  Human immunodeficiency virus and cervical neoplasia. Gynecol Oncol . 1990;;38:377-382.
51 +
Fruchter R, Maiman M, Serur E, et al.  Cervical intraepithelial neoplasia in HIV-infected women.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract MoB0057.
52 +
Maiman M, Tarricone N, Vieira J, et al.  Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstet Gynecol . 1991;;78: 84-88.
53 +
US Preventive Services Task Force.  Screening for chlamydial infections.  In: Fisher M, ed. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions . Baltimore, Md: Williams & Wilkins; 1989;:147-150.
54 +
US Preventive Services Task Force.  Screening for gonorrhea.  In: Fisher M, ed. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions . Baltimore, Md: Williams & Wilkins; 1989;:135-138.
55 +
Hoegsberg B, Abulafia O, Sedlis A, et al.  Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease. Am J Obstet Gynecol . 1990;; 163:1135-1139.
56 +
Safrin S, Dattel BJ, Haver L, et al.  Seroprevalence and epidemiologic correlates of infection in women with acute pelvic inflammatory disease. Obstet Gynecol . 1990;;75:666-670.
57 +
Centers for Disease Control.  Risk for cervical disease in HIV-infected women: New York City. MMWR . 1990;;39:846-849.
58 +
Minkoff HL, Dehovitz JA.  Care of women infected with the human immunodeficiency virus. JAMA . 1991;;266:2253-2258.
59 +
Frazer IH, Crapper RM, Medley G, et al.  Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet . 1986;;2: 657-660.
60 +
Palefsky JM, Gonzales J, Greenblatt RM, et al.  Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease. JAMA . 1990;;263:2911-2916.
61 +
Caussy D, Goedert JJ, Palefsky J, et al.  Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men. Int J Cancer . 1990;;46:214-219.
62 +
Critchlow CW, Holmes KK, Wood R, et al.  Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men. Arch Intern Med . 1992;;152:1673-1680.
63 +
Janssen RS, Saykin AJ, Kaplan JE, et al.  Neurological complications of human immuno-deficiency virus infection in patients with lymphadenopathy syndrome. Ann Neurol . 1988;;23:49-55.
64 +
World Health Organization. Global Program on AIDS: Report of the Second Consultation on the Neuropsychiatric Aspects of HIV-1 Infection . Geneva, Switzerland: World Health Organization; 1990;.
65 +
Cebul RD, Beck RJ.  Biochemical profiles; applications in ambulatory screening and preadmission testing of adults. Ann Intern Med . 1987;;106: 403-413.
66 +
US Preventive Services Task Force.  Screening for asymptomatic bacteriuria, hematuria, and proteinuria.  In: Fisher M, ed. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions . Baltimore, Md: Williams & Wilkins; 1989;:155-161.
67 +
Bourgoigine J, Meneses R, Pardo V.  The nephropathy related to the acquired immune deficiency syndrome. Adv Nephrol . 1988;;17:113-126.
68 +
Cello JP.  AIDS-associated gastrointestinal disease.  In: Sande MA, Volberding PA, eds. The Medical Management of AIDS . Philadelphia, Pa: WB Saunders Co; 1990;:145-160.
69 +
Hambleton J, Abrams DI.  Hematologic manifestations of HIV infection.  In: Sande MA, Volberding PA, eds. The Medical Management of AIDS . Philadelphia, Pa: WB Saunders Co; 1990;:182-194.
70 +
Karpatkin S.  Immunologic thrombocytopenic purpura in HIV: seropositive homosexuals, narcotic addicts and hemophiliacs. Semin Hematol . 1988;; 25:219-229.
71 +
Beach RS, Morgan R, Wilkie F, et al.  Plasma vitamin B12 level as a potential cofactor in studies of human immunodeficiency virus type 1-related cognitive changes. Arch Neurol . 1992;;49:501-506.
72 +
Beach RS, Mantero-Atienza E, Shor-Posner G, et al.  Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS . 1992;;6:701-708.
73 +
Harriman GR, Smith PD, Home MK, et al.  Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med . 1989;;149:2039-2041.
74 +
Remacha AF, Riera A, Cadafalch J, et al.  Vitamin B-12 abnormalities in HIV-infected patients. Eur J Haematol . 1991;;47:60-64.
75 +
Burkes RL, Cohen H, Krailo M, et al.  Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol . 1987;;38:141-147.
76 +
Baum MK, Beach R, Morgan R, et al.  Vitamin B12 and cognitive function in HIV infection.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract FB32.
77 +
Kieburtz KD, Giang DW, Schiffer RB, Vakil N.  Abnormal vitamin B12 metabolism in human immunodeficiency virus infection: association with neurological dysfunction. Arch Neurol . 1991;;48:312-314.
78 +
Bogden JD, Baker H, Frank O, et al.  Micronutrient status and human immunodeficiency virus infection. Ann N Y Acad Sci . 1990;;587:189-195.
79 +
Baum MK, Mantero-Atienza E, Shor-Posner G, et al.  Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. J Acquir Immune Defic Syndr . 1991;;4:1122-1132.
80 +
Odeh M.  The role of zinc in acquired immunodeficiency syndrome. J Intern Med . 1992;;231:463-469.
81 +
Dworkin BM, Rosenthal WS, Wormser GP, et al.  Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and AIDS-related complex. Biol Trace Elem Res . 1988;;15:167-177.
82 +
Olmsted L, Schrauzer GN, Flores-Arce M, Dowd J.  Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res . 1989;;20:59-65.
83 +
Mantero-Atienza E, Sotomayor MC, Shor-Posner G, et al.  Selenium status and immune function in early HIV-1 infection.  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract MC3126.
84 +
Meeker HC, Eskew ML, Schenchenzuber W.  Antioxidant effects on cell-mediated immunity. J Leuk Biol . 1985;;38:451-458.
85 +
Beach RS, Cabrejos C, Mantero-Atienza E, et al.  Effect of zinc normalization on immunological function in early HIV-1 infection.  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract MC3128.
86 +
Shor-Posner G, Blaney N, Feaster D, et al.  Anxiety and depression in early HIV-1 infection and its association with vitamin B6 status.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3711.
87 +
Coodley G, Girard DE.  Vitamins and minerals in HIV infection. J Gen Intern Med . 1991;;6:472-479.
88 +
Centers for Disease Control.  Syphilis and congenital syphilis: United States, 1985-1988. MMWR . 1988;;37:486-487.
89 +
Centers for Disease Control.  Relationship of syphilis to drug use and prostitution: Connecticut and Philadelphia, Pennsylvania. MMWR . 1988;;37: 755-764.
90 +
Johns DR, Tierney M, Elsensteln D.  Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med . 1987;;316:1569-1572.
91 +
Radolf ID, Kaplan RP.  Unusual manifestations of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol . 1988;;18:423-428.
92 +
McLeish WM, Pulido JS, Holland S, et al.  The ocular manifestations of syphilis in the human immunodeficiency virus type 1-infected host. Ophthalmology . 1990;;97:196-203.
93 +
Caumes E, Michel J, Janssen F, et al.  Atypical secondary syphilis in HIV seropositive patients.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP49.
94 +
Dinubile MJ, Baxter JD, Mirsen TR.  Acute syphilitic meningitis in a man with seropositivity for human immunodeficiency virus infection and normal numbers of CD4 T lymphocytes. Arch Intern Med . 1992;;152:1324-1326.
95 +
Reid S, Umedaly H, Forrest D, et al.  The spectrum of neurosyphilis in HIV-infected individuals.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract MBO33.
96 +
Lukehart SA, Hook EW, Baker-Zander SA, et al.  Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med . 1988;;109:855-862.
97 +
Berry CD, Hooton TM, Collier AC, Lukehart SA.  Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med . 1987;;316:1587-1589.
98 +
Clark R, Carlisle JT.  Neurosyphilis and HIV infection. South Med J . 1988;;81:1204-1205.
99 +
Hay P, Kitchen V, Harris JRW, Goldmeier D.  Failure of benzathine penicillin to eradicate syphilis in HIV positive patients.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP59.
100 +
Malessa R, Bahro M, Brockmeyer N, et al.  Neurosyphilis in HIV-infected patients: evidence of unreliable serologic responses.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP50.
101 +
Hicks CB, Benson PM, Lupton GP, Tramont EC.  Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. Ann Intern Med . 1987;; 107:492-495.
102 +
Haas JS, Bolan G, Larsen SA, et al.  Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis . 1990;;162:862-866.
103 +
Mayer KH, Underdahl J, Saltzman SP, et al.  Infection with syphilis and/or HIV among initially asymptomatic homosexual males, Boston, MA, 1985-1989.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThC634.
104 +
Johnson PDR, Graves SR, Stewart L, et al.  Specific syphilis serological tests may be negative in HIV infection. AIDS . 1991;;5:419-423.
105 +
Alwood K, Hook F, Starkey D, Saah A.  History of and conventional tests for syphilis in HIV-1 seropositive homosexual men in the Baltimore MACS.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP52.
106 +
Terry PM, Page ML, Goldmeier D.  Are serological tests of value in diagnosing and monitoring response to treatment of syphilis in patients infected with human immunodeficiency virus? Genitourin Med . 1988;;64:219-222.
107 +
Musher DM, Hamill RJ, Baughn RE.  Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med . 1990;;113:872-881.
108 +
Centers for Disease Control.  Recommendations for diagnosing and treating syphilis in HIV-infected patients. MMWR . 1988;;37:600-608.
109 +
Israelski DM, Remington JS.  Toxoplasmic encephalitis in patients with AIDS. Infect Dis Clin North Am . 1988;;2:429-445.
110 +
Grant IH, Gold JWM, Rosenblum M, et al.  Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS . 1990;;4:519-521.
111 +
Chuck SI, Sande MA.  Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med . 1989;;321:794-799.
112 +
Nelson MR, Smith DE, Shanson D, et al.  The limited value of routine serum antigen screening for cryptococcal infection.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP17.
113 +
Minamoto G, Armstrong D.  Fungal infections in AIDS: histoplasmosis and coccidioidomycosis. Infect Dis Clin North Am . 1988;;2:447-456.
114 +
Galgiani JN, Ampel NM.  Coccidioidomycosis in human immunodeficiency virus-infected patients. J Infect Dis . 1990;;162:1165-1169.
115 +
Wheat LJ, Connolly-Stringfield PA, Baker RL, et al.  Disseminated histoplasmosis in the acquired immunodeficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine . 1990;;69:361-374.
116 +
Ampel NM, Dols CL, Galgiani JN.  Coccidioidomycosis during HIV infection: a continuing prospective study.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThB469.
117 +
Barnes PF, Bloch AB, Davidson PT, Snider DE.  Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med . 1991;; 324:1644-1650.
118 +
Selwyn PA, Hartel D, Lewis VA, et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med . 1989;;320:545-550.
119 +
Daley CL, Small PM, Schecter GF, et al.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med . 1992;;326:231-235.
120 +
Centers for Disease Control.  Diagnosis and management of mycobacterial infection and disease in persons with human T-lymphotropic virus type-III lymphadenopathy-associated virus infection. MMWR . 1986;;35:448-452.
121 +
Centers for Disease Control.  Screening for tuberculosis and tuberculous infection in high-risk populations. MMWR . 1990;;39( (RR-8) ):1-7.
122 +
Graham NMH, Nelson KE, Solomon L, et al.  Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA . 1992;;267:369-373.
123 +
Huebner RE, Villarino ME, Snider DE.  Tuberculin skin testing and the HIV epidemic. JAMA . 1992;;267:409-410.
124 +
Centers for Disease Control.  Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR . 1991;;40( (RR-5) ):27-33.
125 +
Centers for Disease Control.  Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR . 1990;;39( (RR-2) ):5-22.
126 +
Lebovic E, Dworkin BM, Heier SK, et al.  The hepatobiliary manifestations of human immunodeficiency virus infection. Am J Gastroenterol . 1988;; 83:1-7.
127 +
Griffin PM, Tauxe RV.  Food counseling for patients with AIDS. J Infect Dis . 1988;;158:668.
128 +
Janoff EN, Breiman RF, Daley CL, Hopewell PC.  Pneumococcal disease during HIV infection. Ann Intern Med . 1992;;117:314-324.
129 +
Centers for Disease Control.  Recommendations of the Immunization Practices Advisory Committee: pneumococcal polysaccharide vaccine. MMWR . 1989;;38:64-76.
130 +
Schlamm HT, Yancovitz SR.  Haemophilus influenzae pneumonia in young adults with AIDS, ARC, or risk of AIDS. Am J Med . 1989;;86:11-14.
131 +
Casadevall A, Dobroszycki J, Small C, Pirofski L.  Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS. Am J Med . 1992;;92:587-590.
132 +
Steinhoff MC, Auerbach BS, Nelson KE, et al.  Antibody responses to Haemophilus influenzae type b vaccines in men with human immunodeficiency virus infection. N Engl J Med . 1991;;325: 1837-1842.
133 +
Farley MM, Stephens DS, Brachman PS, et al.  Invasive Haemophilus influenzae disease in adults: a prospective, population-based surveillance. Ann Intern Med . 1992;;116:806-812.
134 +
Centers for Disease Control.  Increase in pneumonia mortality among young adults and the HIV epidemic: New York City, United States. MMWR . 1988;;37:593-596.
135 +
Selwyn PA, Feingold AR, Hartel D, et al.  Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without acquired immunodeficiency syndrome. AIDS . 1988;;2:267-72.
136 +
Centers for Disease Control.  Prevention and control of influenza recommendations of the immunization practices advisory committee (ACIP). MMWR . 1992;;41( (RR-9) ):1-17.
137 +
Hadler SC, Judson FN, O'Malley PM, et al.  Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis . 1991;;163: 454-459.
138 +
Hadler SC.  Hepatitis b prevention and human immunodeficiency virus (HIV) infection. Ann Intern Med . 1988;;109:92-94.
139 +
Huang KL, Ruben FL, Rinaldo CR, et al.  Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA . 1987;;257:2047-2050.
140 +
Klein RS, Selwyn PA, Maude D, et al.  Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous dryg users infected with human immunodeficiency virus. J Infect Dis . 1989;;160:826-831.
141 +
Nelson KE, Clements ML, Miotti P, et al.  The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med . 1988;;109:383-388.
142 +
Ballet JJ, Sulcebe G, Couderc LJ, et al.  Impaired anti-pneumococcal antibody response in patients with AIDS related persistent generalized lymphadenopathy. Clin Exp Immunol . 1987;;68:479-487.
143 +
Ragni MV, Ruben FL, Winkelstein A, et al.  Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med . 1987;; 109:545-549.
144 +
Ochs HD, Junder AK, Collier AC, et al.  Abnormal antibody responses in patients with persistent generalized lymphadenopathy. J Clin Immunol . 1988;;8:57-63.
145 +
Janoff EN, Douglas JM, Gabriel M, et al.  Class-specific antibody response to pneumococcal capsular polysaccharide in men infected with human immunodeficiency virus type 1. J Infect Dis . 1988;; 158:983-990.
146 +
Collier AC, Corey L, Murphy VL, et al.  Antibody to human immunodeficiency virus and suboptimal response to hepatitis B vaccination. Ann Intern Med . 1988;;109:101-105.
147 +
Carne CA, Weller IVD, Waite J, et al.  Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. BMJ . 1987;;294:866-868.
148 +
Gesemann M, Scheiermann N, Brockmeyer N, et al.  Clinical evaluation of a recombinant hepatitis B vaccine in HIV-infected vs uninfected persons.  In: Zuckerman AJ, ed. Viral Hepatitis and Liver Disease . New York, NY: Alan R Liss; 1988;:1076-1078.
149 +
Loke RHT, Murray-Lyon IM, Coleman JC, et al.  Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis. J Med Virol . 1990;;31: 109-111.
150 +
Bruguera M, Cremades M, Salinas R, et al.  Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol . 1992;;14:27-30.
151 +
Opravil M, FIerz W, Matter L, et al.  Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol . 1991;;84:185-189.
152 +
Miotti PG, Nelson KE, Dallabetta GA, et al.  The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA . 1989;;262:779-783.
153 +
Vardinon N, Handsher R, Burke M, et al.  Poliovirus vaccination responses in HIV-infected patients: correlation with T4 counts. J Infect Dis . 1990;;162:238-241.
154 +
Masur H, Michelis MA, Greene JB, et al.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med . 1981;;305:1431-1438.
155 +
Redfield RR, Wright DC, James WD, et al.  Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med . 1987;;316:673-676.
156 +
Centers for Disease Control.  Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome. MMWR . 1986;;34:227-228.
157 +
Sprauer M, Markowitz L, Dales L, et al.  Evaluation of measles and rubella vaccination among HIV-infected adults.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThB542.
158 +
McLaughlin M, Thomas P, Onorato I, et al.  Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey. Pediatrics . 1988;;82:229-233.
159 +
Klein RS.  Prophylaxis of opportunistic infections in individuals infected with HIV. AIDS . 1989;; 3( (suppl 1) ):S161-S173.
160 +
Pinching AJ.  Editorial review: prophylactic and maintenance therapy for opportunistic infections in AIDS. AIDS . 1988;;2:335-343.
161 +
Greenspan JS, Greenspan D, Winkler JR.  Diagnosis and management of the oral manifestations of HIV infection and AIDS. Infect Dis Clin North Am . 1988;;2:387-396.
162 +
Gombert ME, duBouchet L, Aulicino TM, Butt KM.  A comparative trial of clotrimazole troches and oral nystatin suspension in recipients of renal transplants: use in prophylaxis of oropharyngeal candidiasis. JAMA . 1987;;258:2553-2555.
163 +
Leen CL, Dunbar EM, Ellis ME, et al.  Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. J Infect . 1990;;21:55-60.
164 +
Stevens DA, Greene I, Lang OS.  Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome—related complex: randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch Intern Med . 1991;;151: 2458-2464.
165 +
Just-Nubling G, Gentschew G, Meissner K, et al.  Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Microbiol Infect Dis . 1991;;10:917-921.
166 +
Klein RS.  Prophylaxis of opportunistic infections in individuals infected with HIV. AIDS . 1989;; 3( (suppl 1) ):S161-S173.
167 +
Blasdon MJ, Tobin JM.  Recurrent vaginal candidiasis: prospective study of effectiveness of maintenance miconazole treatment. Genitourin Med . 1988;;64:124-127.
168 +
Roth AC, Milsom L, Forssman, Wahlen P.  Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet. Genitourin Med . 1990;;66:357-360.
169 +
Sobel JD.  Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med . 1986;;315:1455-1458.
170 +
Powderly WG, Saag MS, Cloud GA, et al.  A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med . 1992;;326:793-798.
171 +
Nightingale SD, Cal SX, Peterson DM, et al.  Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS . 1992;;6:191-194.
172 +
Sprinz E, Matias K.  Cryptococcal meningitis prophylaxis with ketoconazole in patients with AIDS.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3261.
173 +
Castellano AR, Nettleman MD.  Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia. JAMA . 1991;;266:820-824.
174 +
Fischl MA, Dickinson GM, La Voie L.  Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA . 1988;;259:1185-1189.
175 +
MacGregor RR, Morgan AS, Graziani AL, et al.  Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients. Am J Med . 1992;;92:227-229.
176 +
Hirschel B, Lazzarin A, Chopard P, et al.  A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med . 1991;;324:1079-1083.
177 +
Blum NR, Miller LA, Gaggin N, Cohn DL.  Comparative trial of dapsone versus trimethoprim/ sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr . 1992;;5:341-347.
178 +
Kemper CA, Tucker RM, Lang OS, et al.  Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex. AIDS . 1990;;4:1145-1148.
179 +
Metroka CE, Jacobus D, Lewis N.  Successful chemoprophylaxis for Pneumocystis with dapsone or Bactrim.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract TBO4.
180 +
Carr A, Tindall B, Brew BJ, et al.  Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med . 1992;;117:106-111.
181 +
Youle M.  Double blind, placebo controlled trial of high dose acyclovir for the prevention of cytomegalovirus (CMV) disease in late stage HIV disease.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract MoB0056.
182 +
Drew WL.  Herpes virus infection (infections caused by cytomegalovirus, herpes simplex virus, varicella-zoster virus): how to use gancyclovir (DHPG) and acyclovir. Infect Dis Clin North Am . 1988;;2:495-510.
183 +
Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group.  Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med . 1992;;326:213-220.
184 +
Conant MA.  Prophylactic and suppressive treatment with acyclovir and the management of herpes in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol . 1988;;18:186-188.
185 +
Mindel A, Faherty A, Carney O, et al.  Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet . 1988;;1: 926-928.
186 +
Wadhawan D, Hira S, Mwansa N, et al.  Isoniazid prophylaxis among patients with HIV-1 infection.  In: Program and abstract of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThB510.
187 +
Centers for Disease Control.  The use of preventive therapy for tuberculous infection in the United States. MMWR . 1990;;39( (RR-8) ):9-12.
188 +
Chaisson RE, Slutkin G.  Tuberculosis and human immunodeficiency virus infection. J Infect Dis . 1989;;159:96-100.
189 +
Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE.  High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA . 1992;;268:504-509.
190 +
Small PM, Schecter GF, Goodman PC, et al.  Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med . 1991;;324:289-294.
191 +
Gordin F, Nightingale S, Wynne B, et al.  Rifabutin monotherapy prevents or delays mycobacterium avium complex (MAC) bacteremia in patients with AIDS.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3081.
192 +
Cotton D, Weinberg D.  Survey results: treatment decisions in HIV care. AIDS Clin Care . 1992;; 4:85-91.
193 +
Carr A, Tindall B, Penny R, Cooper DA.  Trimethoprim-sulfamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. AIDS . 1992;;6:165-171.
194 +
Martin MA, Cox PH, Beck K, et al.  A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch Intern Med . 1992;;152:523-528.
195 +
Mallolas J, Zamora L, Gatell JM, et al.  Low-dose co-trimoxazole, aerosolized pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia. Lancet . 1991;;337:1162-1163.
196 +
Torres RA, Barr M, Thorn M, et al.  Pneumocystis prophylaxis failures: a comparison of aerosolized pentamidine and dapsone.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3321.
197 +
Soloway B, Hecht F.  Changing approaches to PCP prophylaxis. AIDS Clin Care . 1992;;4:61-64.
198 +
Torres R, Thorn M, Barr M, et al.  Dapsone prophylaxis for toxoplasmosis and Pneumocystis carinii pneumonia.  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract WB2248.
199 +
Rich JD, Kazanjian PH, Hunter DJ, Maguire JH.  The effect of chemoprophylaxis for Pneumocystis carinii pneumonia (PCP) on development of reactivation toxoplasmosis.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3244.
200 +
Nielsen TL, Jensen BN, Mathiesen GJ, et al.  Secondary Pneumocystis prophylaxis (SPP): a prospective study with low dose sulfamethoxazole-trimethoprim (SMX-TMP) vs low dose aerosolized pentamidine (AP).  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract WB2224.
201 +
Heald A, Flepp M, Chave JP, et al.  Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med . 1991;;115:760-763.
202 +
Kent RS. Data Concerning Pyrimethamine (Daraprim) . Letter to physicians from Burroughs Wellcome Co, Research Triangle Park, NC, August 10, 1992;.
203 +
Fischl MA, Richman DD, Grieco MH, et al.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med . 1987;;317:185-191.
204 +
Volberding PA, Lagakos SW, Koch MA, et al.  Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med . 1990;;322:941-949.
205 +
Fischl MA, Richman DD, Hansen N, et al.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Ann Intern Med . 1990;;112:727-737.
206 +
Hamilton JD, Hartigan PM, Simberkoff MS, et al.  A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: results of the Veterans Affairs Cooperative Study. N Engl J Med . 1992;;326:437-443.
207 +
Graham NMH, Zeger SL, Park LP, et al.  The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med . 1992;;326:1037-1042.
208 +
McLeod GX, Hammer SM.  Zidovudine: five years later. Ann Intern Med . 1992;;117:487-501.
209 +
Corey L, Fleming TR.  Treatment of HIV infection: progress in perspective. N Engl J Med . 1992;;326:484-485.
210 +
 Zidovudine for symptomless HIV infection. Lancet . 1990;;335:821-822. Editorial.
211 +
Ruedy J, Schechter M, Montaner JSG.  Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how? Ann Intern Med . 1990;;112:721-723.
212 +
Gazzard BG.  When should asymptomatic patients with HIV infection be treated with zidovudine? BMJ . 1992;;304:456-457.
213 +
Kahn JO, Lagakos SW, Richman DD, et al.  A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med . 1992;;327:581-587.
214 +
Groopman JE, Molina JM.  Nucleoside therapy for HIV infection: some answers, many questions. N Engl J Med . 1992;;327:639-641.
215 +
Abrams DI, Grieco MH, eds. AIDS/HIV Treatment Directory . Washington, DC: American Foundation for AIDS Research; 1991;.
216 +
Sachs MK.  Antiretroviral chemotherapy of human immunodeficiency virus infections other than with azidothymidine. Arch Intern Med . 1992;;152: 485-501.
217 +
Cohen M.  Chinese medicine in the treatment of chronic immunodeficiency: diagnosis and treatment. Am J Acupunct . 1990;;18:111-122.
218 +
Moseson M, Zeleniuch-Jacquotte A, Belsito DY, et al.  The potential role of nutritional factors in the induction of immunologic abnormalities in HIV-positive homosexual men. J Acquir Immune Defic Syndr . 1989;;2:235-247.
219 +
Schlenzig C, Rieder JH, Hammel G, Popescu M.  Supervised physical exercise leads to psychological and immunological improvement in pre-AIDS patients.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract TBP301.
220 +
Royce RA, Winkelstein W.  HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study. AIDS . 1990;;4:327-333.
221 +
Becker MH, Brooks-Gunn J, Coates TJ, et al.  Facilitating change in health behaviors.  In: Miller HG, ed. AIDS: Sexual Behavior and Intravenous Drug Use . Washington, DC: National Academy Press; 1989;:259-315.
222 +
Kotler DP.  Nutritional support in AIDS. Am J Gastroenterol . 1991;;86:539-541.
223 +
 Nutrition and HIV. Lancet . 1991;;338:86-87. Editorial.
224 +
Heckler LM, Kotler DP.  Malnutrition in patients with AIDS. Nutr Rev . 1990;;48:393-401.
225 +
Laperriere AR, Antoni MH, Schneiderman N, et al.  Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback Self Regul . 1990;;15:229-242.
226 +
Schlenzig C, Jaeger H, Wehrenberg M, et al.  Physical exercise favorably influences the course of illness in patients with HIV and AIDS.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3401.
227 +
Buskin SE, Hopkins SG, Farizo KM.  Heavy smoking increases the risk of Pneumocystis carinii pneumonia (PCP).  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract WeC1030.
228 +
Nieman R, Fleming J, Coker RJ, et al.  Cigarette smoking by HIV infected individuals is associated with a more rapid progression to AIDS.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoC4407.
229 +
Weber R, Ledergerber B, Opravil M, et al.  Progression of HIV infection in misusers of injected drugs who stop injecting or follow a program of maintenance treatment with methadone. BMJ . 1990;; 301:1362-1365.
230 +
Seber R, Ledergerber B, Opravil M, et al.  Cessation of intravenous drug use reduces progression of HIV-infection in HIV+ drug users.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThC36.
231 +
Kaslow RA, Blackwelder WC, Ostrow DG, et al.  No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1—positive individuals: a report from the Multicenter AIDS Cohort Study. JAMA . 1989;;261: 3424-3429.
232 +
Brown LS, Siddiqui N.  Relationship between cocaine use and HIV disease progression in injecting drug users (IDUs).  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract MC3156.
233 +
Feldman DA, ed. Culture and AIDS . New York, NY: Praeger Publishers; 1990;.
234 +
Wolcott DL.  Psychosocial aspects of acquired immune deficiency syndrome and the primary care physician. Ann Allergy . 1986;;57:95-102.
235 +
Holland JC, Tross S.  The psychosocial and neuropsychiatric sequelae of the acquired immunodeficiency syndrome and related disorders. Ann Intern Med . 1985;;103:760-764.
236 +
Dew MA, Ragni MV, Nimorwicz P.  Infection with human immunodeficiency virus and vulnerability to psychiatric distress: a study of men with hemophilia. Arch Gen Psychiatry . 1990;;47:737-744.
237 +
Perry SW, Markowitz J.  Psychiatric interventions for AIDS-spectrum disorders. Hosp Community Psychiatry . 1987;;37:1001-1006.
238 +
Kelly JA, St Lawrence JS. The AIDS Health Crisis: Psychological and Social Interventions . New York, NY: Plenum Press; 1988;.
239 +
Katoff L, Dunne R.  Supporting people with AIDS: the Gay Men's Health Crisis model. J Palliat Care . 1988;;4:88-95.
240 +
Perry S, Fishman B, Jacobsberg L, et al.  Effectiveness of psychoeducational interventions in reducing emotional distress after human immunodeficiency virus antibody testing. Arch Gen Psychiatry . 1991;;48:143-147.
241 +
Kelly PJ.  Evaluation of a meditation and hypnosis-based stress management program for men with HIV.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract WDP17.
242 +
Zich J, Temoshok L.  Perceptions of social support, distress and hopelessness in men with AIDS and ARC: clinical implications.  In: Temoshok L, Baum A, eds. Psychosocial Perspectives on AIDS: Etiology, Prevention, and Treatment . Hillsdale, NJ: Lawrence Erlbaum Associates Inc; 1990;:201-227.
243 +
Gremmen T, VanDemboom FMLG, Witlox R.  Self help groups for PWAs show positive results.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3802.
244 +
Mulder C, Emmelkamp PMG, Mulder JW, et al.  Immunological and psychosocial effects of a cognitive-behavioral vs an experiential group therapy program for asymptomatic HIV seropositive homosexual men.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3809.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

1 +
Lemp GF, Payne SF, Neal D, et al.  Survival trends for patients with AIDS. JAMA . 1990;;263: 402-406.
2 +
Harris JE.  Improved short-term survival of AIDS patients initially diagnosed with Pneumocystis carinii pneumonia, 1984-1987. JAMA . 1990;;263:397-401.
3 +
Centers for Disease Control.  Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR . 1987;;36( (suppl 1S) ):1S-15S.
4 +
Stein DS, Korvick JA, Vermund SH.  CD4 lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis . 1992;;165:352-363.
5 +
Taylor JMG, Fahey JL, Detels R, et al.  CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use. J Acquir Immune Defic Syndr . 1989;;2:114-124.
6 +
Burcham J, Marmor M, Dubin N, et al.  CD4% is the best predictor of development of AIDS in a cohort of HIV-infected homosexual men. AIDS . 1991;;5:365-372.
7 +
Centers for Disease Control.  Guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus infection. MMWR . 1992;;41( (RR-8) ):1-16.
8 +
Malone JL, Simms TE, Gray GC, et al.  Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patents: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr . 1990;;3:144-151.
9 +
Hoover DR, Graham HMH, Chen B, et al.  Effect of CD4+ cell count measurement variability on staging HIV-1 infection. J Acquir Immune Defic Syndr . 1992;;5:794-802.
10 +
Munoz A, Vlahov D, Solomon L, et al.  Prognostic indicators for development of AIDS among intravenous drug users. J Acquir Immune Defic Syndr . 1992;;5:694-700.
11 +
Moss AR, Bacchetti P, Osmond D, et al.  Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. BMJ . 1988;;296:745-750.
12 +
Fahey JL, Taylor JMG, Detal R, et al.  The prognostic value of cellular and serological markers in infection with human immunodeficiency virus type 1. N Engl J Med . 1990;;322:166-172.
13 +
Anderson RE, Lang W, Shiboski S, et al.  Use of β-2 microglobulin level and CD4 lymphocyte count to predict development of acquired immunodeficiency syndrome in persons with human immunodeficiency virus infection. Arch Intern Med . 1990;; 150:73-77.
14 +
Hofmann B, Wand Y, Cumberland WG, et al.  Serum beta-2-microglobulin level increases in HIV infection: relation to seroconversion, CD4 T-cell fall and prognosis. AIDS . 1990;;4:207-214.
15 +
Lifson AR, Hessol NA, Buchbinder SP, et al.  Serum β2-microglobulin and prediction of progression to AIDS in HIV infection. Lancet . 1992;;339: 1436-1440.
16 +
Melmed RN, Taylor JMG, Detels R, et al.  Serum neopterin changes in HIV-infected subjects: indicator of significant pathology, CD4 T cell changes, and the development of AIDS. J Acquir Immune Defic Syndr . 1989;;2:70-76.
17 +
Kramer A, Wiktor SZ, Fuchs D, et al.  Neopterin: a predictive marker of acquired immune deficiency syndrome in human immunodeficiency virus infection. J Acquir Immune Defic Syndr . 1989;; 2:291-296.
18 +
Zangerle R, Fuchs D, Rebnegger G, et al.  Markers for disease progression in intravenous drug users infected with HIV-1. AIDS . 1991;;5: 985-991.
19 +
Chaisson RE, Taylor E, Margolick JB, et al.  Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users. J Acquir Immune Defic Syndr . 1992;;5:456-460.
20 +
Flegg PJ, Brettle RP, Robertson JR, et al.  β2-microglobulin levels in drug users: the influence of risk behavior. AIDS . 1991;;5:1021-1024.
21 +
Pedersen C, Nielsen CM, Vestergaard BF, et al.  Temporal relation of antigenaemia and loss of antibodies to core antigens to development of clinical disease in HIV infection. BMJ . 1987;;295:567-569.
22 +
Forster SM, Osborne LM, Cheingsong-Popov R, et al.  Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection. AIDS . 1987;;1:235-240.
23 +
Macdonell KB, Chmiel JS, Poggensee L, et al.  Predicting progression to AIDS: combined usefulness of CD4 lymphocyte counts and p24 antigenemia. Am J Med . 1990;;89:706-712.
24 +
Phair J, Munoz A, Detels R, et al.  The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type I. N Engl J Med . 1990;;322:161-165.
25 +
Centers for Disease Control.  Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR . 1992;;41( (RR-4) ):1-11.
26 +
National Institute of Allergy and Infectious Diseases.  Recommendations for zidovudine: early infection. JAMA . 1990;;263:1606, 1609.
27 +
Lang W, Perkins H, Anderson RE, et al.  Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr . 1989;;2:63-69.
28 +
Hardy WD.  Prophylaxis of AIDS-related opportunistic infections (OIs): current status and future strategies.  In: Volberding P, Jacobson MA, eds. Clinical AIDS Review 1991 . New York, NY: Marcel Dekker Inc; 1991;:145-180.
29 +
Freedberg KA, Tosteson ANA, Cotton DJ, Goldman L.  Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effectiveness analysis. J Gen Intern Med . 1992;;7:261-272.
30 +
Polis M, Masur H.  Predicting the progression to AIDS. Am J Med . 1990;;89:701-705.
31 +
US Preventive Services Task Force. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions . Baltimore, Md: Williams & Wilkins; 1989;.
32 +
Brenner M, Ognibene FP, Lack EE, et al.  Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia. Am Rev Respir Dis . 1987;;136:1199-1206.
33 +
Krumholz HM, Sullam PM, Tager IB.  Predictors of mortality in patients with AIDS and Pneumocystis carinii pneumonia (PCP).  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract MBP375.
34 +
Dover JS, Johnson RA.  Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol . 1991;;127(pt 1):1383-1391.
35 +
Dover JS, Johnson RA.  Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol . 1991;;127(pt 2):1549-1558.
36 +
Rosenberg PR, Uliss AE, Friedland GH, et al.  Acquired immunodeficiency syndrome: ophthalmic manifestations in ambulatory patients. Ophthalmology . 1983;;90:874-878.
37 +
Palestine AG, Rodrigues MM, Macher AM, et al.  Ophthalmic involvement in acquired immunodeficiency syndrome. Ophthalmology . 1984;;91:1092-1099.
38 +
Bloom JN, Palestine AG.  The diagnosis of cytomegalovirus retinitis. Ann Intern Med . 1988;;109: 963-969.
39 +
Henderly DE, Freeman WR, Causey, et al.  Cytomegalovirus retinitis and response to therapy with gancyclovir. Ophthalmology . 1987;;94: 425-434.
40 +
Bottles K, McPhaul LW, Volberding P.  Fine-needle aspiration biopsy of patients with the acquired immunodeficiency syndrome (AIDS): experience in an outpatient clinic. Ann Intern Med . 1988;;108:42-45.
41 +
Shapiro AL, Pincus RL.  Fine-needle aspiration of diffuse cervical lymphadenopathy in patients with acquired immunodeficiency syndrome. Otolaryngol Head Neck Surg . 1991;;105:419-421.
42 +
Rhoads JL, Wright DC, Redfield RR, Burke DS.  Chronic vaginal candidiasis in women with human immunodeficiency virus infection. JAMA . 1987;; 257:3105-3107.
43 +
Imam W, Carpenter CJ, Mayer K, et al.  Hierarchical pattern of mucosal candida infection in HIV seropositive women. Am J Med . 1990;;89:142-146.
44 +
Byrne MA, Taylor-Robinson D, Munday PE, Harris JRW.  The common occurrence of human papillomavirus infection and intraepithelial neoplasia in women infected by HIV. AIDS . 1989;;3:379-382.
45 +
Schrager LK, Friedland GH, Maude D, et al.  Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Syndr . 1989;;2:570-575.
46 +
Schafer A, Friedmann W, Mielke M, et al.  The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol . 1991;;164:593-599.
47 +
Vermund SH, Kelley KF, Klein RS, et al.  High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. Am J Obstet Gynecol . 1991;;165:392-400.
48 +
Matorras R, Ariceta JM, Rementeria A, et al.  Human immunodeficiency virus-induced immunosuppression: a risk factor for human papillomavirus infection. Am J Obstet Gynecol . 1991;;164:42-44.
49 +
Johnson JC, Burnett AF, Willet GD, et al.  High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women. Obstet Gynecol . 1992;;79:321-327.
50 +
Maiman M, Fruchter RG, Serur E, et al.  Human immunodeficiency virus and cervical neoplasia. Gynecol Oncol . 1990;;38:377-382.
51 +
Fruchter R, Maiman M, Serur E, et al.  Cervical intraepithelial neoplasia in HIV-infected women.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract MoB0057.
52 +
Maiman M, Tarricone N, Vieira J, et al.  Colposcopic evaluation of human immunodeficiency virus-seropositive women. Obstet Gynecol . 1991;;78: 84-88.
53 +
US Preventive Services Task Force.  Screening for chlamydial infections.  In: Fisher M, ed. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions . Baltimore, Md: Williams & Wilkins; 1989;:147-150.
54 +
US Preventive Services Task Force.  Screening for gonorrhea.  In: Fisher M, ed. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions . Baltimore, Md: Williams & Wilkins; 1989;:135-138.
55 +
Hoegsberg B, Abulafia O, Sedlis A, et al.  Sexually transmitted diseases and human immunodeficiency virus infection among women with pelvic inflammatory disease. Am J Obstet Gynecol . 1990;; 163:1135-1139.
56 +
Safrin S, Dattel BJ, Haver L, et al.  Seroprevalence and epidemiologic correlates of infection in women with acute pelvic inflammatory disease. Obstet Gynecol . 1990;;75:666-670.
57 +
Centers for Disease Control.  Risk for cervical disease in HIV-infected women: New York City. MMWR . 1990;;39:846-849.
58 +
Minkoff HL, Dehovitz JA.  Care of women infected with the human immunodeficiency virus. JAMA . 1991;;266:2253-2258.
59 +
Frazer IH, Crapper RM, Medley G, et al.  Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet . 1986;;2: 657-660.
60 +
Palefsky JM, Gonzales J, Greenblatt RM, et al.  Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease. JAMA . 1990;;263:2911-2916.
61 +
Caussy D, Goedert JJ, Palefsky J, et al.  Interaction of human immunodeficiency and papilloma viruses: association with anal epithelial abnormality in homosexual men. Int J Cancer . 1990;;46:214-219.
62 +
Critchlow CW, Holmes KK, Wood R, et al.  Association of human immunodeficiency virus and anal human papillomavirus infection among homosexual men. Arch Intern Med . 1992;;152:1673-1680.
63 +
Janssen RS, Saykin AJ, Kaplan JE, et al.  Neurological complications of human immuno-deficiency virus infection in patients with lymphadenopathy syndrome. Ann Neurol . 1988;;23:49-55.
64 +
World Health Organization. Global Program on AIDS: Report of the Second Consultation on the Neuropsychiatric Aspects of HIV-1 Infection . Geneva, Switzerland: World Health Organization; 1990;.
65 +
Cebul RD, Beck RJ.  Biochemical profiles; applications in ambulatory screening and preadmission testing of adults. Ann Intern Med . 1987;;106: 403-413.
66 +
US Preventive Services Task Force.  Screening for asymptomatic bacteriuria, hematuria, and proteinuria.  In: Fisher M, ed. Guide to Clinical Preventive Services: An Assessment of the Effectiveness of 169 Interventions . Baltimore, Md: Williams & Wilkins; 1989;:155-161.
67 +
Bourgoigine J, Meneses R, Pardo V.  The nephropathy related to the acquired immune deficiency syndrome. Adv Nephrol . 1988;;17:113-126.
68 +
Cello JP.  AIDS-associated gastrointestinal disease.  In: Sande MA, Volberding PA, eds. The Medical Management of AIDS . Philadelphia, Pa: WB Saunders Co; 1990;:145-160.
69 +
Hambleton J, Abrams DI.  Hematologic manifestations of HIV infection.  In: Sande MA, Volberding PA, eds. The Medical Management of AIDS . Philadelphia, Pa: WB Saunders Co; 1990;:182-194.
70 +
Karpatkin S.  Immunologic thrombocytopenic purpura in HIV: seropositive homosexuals, narcotic addicts and hemophiliacs. Semin Hematol . 1988;; 25:219-229.
71 +
Beach RS, Morgan R, Wilkie F, et al.  Plasma vitamin B12 level as a potential cofactor in studies of human immunodeficiency virus type 1-related cognitive changes. Arch Neurol . 1992;;49:501-506.
72 +
Beach RS, Mantero-Atienza E, Shor-Posner G, et al.  Specific nutrient abnormalities in asymptomatic HIV-1 infection. AIDS . 1992;;6:701-708.
73 +
Harriman GR, Smith PD, Home MK, et al.  Vitamin B12 malabsorption in patients with acquired immunodeficiency syndrome. Arch Intern Med . 1989;;149:2039-2041.
74 +
Remacha AF, Riera A, Cadafalch J, et al.  Vitamin B-12 abnormalities in HIV-infected patients. Eur J Haematol . 1991;;47:60-64.
75 +
Burkes RL, Cohen H, Krailo M, et al.  Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol . 1987;;38:141-147.
76 +
Baum MK, Beach R, Morgan R, et al.  Vitamin B12 and cognitive function in HIV infection.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract FB32.
77 +
Kieburtz KD, Giang DW, Schiffer RB, Vakil N.  Abnormal vitamin B12 metabolism in human immunodeficiency virus infection: association with neurological dysfunction. Arch Neurol . 1991;;48:312-314.
78 +
Bogden JD, Baker H, Frank O, et al.  Micronutrient status and human immunodeficiency virus infection. Ann N Y Acad Sci . 1990;;587:189-195.
79 +
Baum MK, Mantero-Atienza E, Shor-Posner G, et al.  Association of vitamin B6 status with parameters of immune function in early HIV-1 infection. J Acquir Immune Defic Syndr . 1991;;4:1122-1132.
80 +
Odeh M.  The role of zinc in acquired immunodeficiency syndrome. J Intern Med . 1992;;231:463-469.
81 +
Dworkin BM, Rosenthal WS, Wormser GP, et al.  Abnormalities of blood selenium and glutathione peroxidase activity in patients with acquired immunodeficiency syndrome and AIDS-related complex. Biol Trace Elem Res . 1988;;15:167-177.
82 +
Olmsted L, Schrauzer GN, Flores-Arce M, Dowd J.  Selenium supplementation of symptomatic human immunodeficiency virus infected patients. Biol Trace Elem Res . 1989;;20:59-65.
83 +
Mantero-Atienza E, Sotomayor MC, Shor-Posner G, et al.  Selenium status and immune function in early HIV-1 infection.  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract MC3126.
84 +
Meeker HC, Eskew ML, Schenchenzuber W.  Antioxidant effects on cell-mediated immunity. J Leuk Biol . 1985;;38:451-458.
85 +
Beach RS, Cabrejos C, Mantero-Atienza E, et al.  Effect of zinc normalization on immunological function in early HIV-1 infection.  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract MC3128.
86 +
Shor-Posner G, Blaney N, Feaster D, et al.  Anxiety and depression in early HIV-1 infection and its association with vitamin B6 status.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3711.
87 +
Coodley G, Girard DE.  Vitamins and minerals in HIV infection. J Gen Intern Med . 1991;;6:472-479.
88 +
Centers for Disease Control.  Syphilis and congenital syphilis: United States, 1985-1988. MMWR . 1988;;37:486-487.
89 +
Centers for Disease Control.  Relationship of syphilis to drug use and prostitution: Connecticut and Philadelphia, Pennsylvania. MMWR . 1988;;37: 755-764.
90 +
Johns DR, Tierney M, Elsensteln D.  Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med . 1987;;316:1569-1572.
91 +
Radolf ID, Kaplan RP.  Unusual manifestations of secondary syphilis and abnormal humoral immune response to Treponema pallidum antigens in a homosexual man with asymptomatic human immunodeficiency virus infection. J Am Acad Dermatol . 1988;;18:423-428.
92 +
McLeish WM, Pulido JS, Holland S, et al.  The ocular manifestations of syphilis in the human immunodeficiency virus type 1-infected host. Ophthalmology . 1990;;97:196-203.
93 +
Caumes E, Michel J, Janssen F, et al.  Atypical secondary syphilis in HIV seropositive patients.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP49.
94 +
Dinubile MJ, Baxter JD, Mirsen TR.  Acute syphilitic meningitis in a man with seropositivity for human immunodeficiency virus infection and normal numbers of CD4 T lymphocytes. Arch Intern Med . 1992;;152:1324-1326.
95 +
Reid S, Umedaly H, Forrest D, et al.  The spectrum of neurosyphilis in HIV-infected individuals.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract MBO33.
96 +
Lukehart SA, Hook EW, Baker-Zander SA, et al.  Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Intern Med . 1988;;109:855-862.
97 +
Berry CD, Hooton TM, Collier AC, Lukehart SA.  Neurologic relapse after benzathine penicillin therapy for secondary syphilis in a patient with HIV infection. N Engl J Med . 1987;;316:1587-1589.
98 +
Clark R, Carlisle JT.  Neurosyphilis and HIV infection. South Med J . 1988;;81:1204-1205.
99 +
Hay P, Kitchen V, Harris JRW, Goldmeier D.  Failure of benzathine penicillin to eradicate syphilis in HIV positive patients.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP59.
100 +
Malessa R, Bahro M, Brockmeyer N, et al.  Neurosyphilis in HIV-infected patients: evidence of unreliable serologic responses.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP50.
101 +
Hicks CB, Benson PM, Lupton GP, Tramont EC.  Seronegative secondary syphilis in a patient infected with the human immunodeficiency virus (HIV) with Kaposi sarcoma. Ann Intern Med . 1987;; 107:492-495.
102 +
Haas JS, Bolan G, Larsen SA, et al.  Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis . 1990;;162:862-866.
103 +
Mayer KH, Underdahl J, Saltzman SP, et al.  Infection with syphilis and/or HIV among initially asymptomatic homosexual males, Boston, MA, 1985-1989.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThC634.
104 +
Johnson PDR, Graves SR, Stewart L, et al.  Specific syphilis serological tests may be negative in HIV infection. AIDS . 1991;;5:419-423.
105 +
Alwood K, Hook F, Starkey D, Saah A.  History of and conventional tests for syphilis in HIV-1 seropositive homosexual men in the Baltimore MACS.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP52.
106 +
Terry PM, Page ML, Goldmeier D.  Are serological tests of value in diagnosing and monitoring response to treatment of syphilis in patients infected with human immunodeficiency virus? Genitourin Med . 1988;;64:219-222.
107 +
Musher DM, Hamill RJ, Baughn RE.  Effect of human immunodeficiency virus (HIV) infection on the course of syphilis and on the response to treatment. Ann Intern Med . 1990;;113:872-881.
108 +
Centers for Disease Control.  Recommendations for diagnosing and treating syphilis in HIV-infected patients. MMWR . 1988;;37:600-608.
109 +
Israelski DM, Remington JS.  Toxoplasmic encephalitis in patients with AIDS. Infect Dis Clin North Am . 1988;;2:429-445.
110 +
Grant IH, Gold JWM, Rosenblum M, et al.  Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS. AIDS . 1990;;4:519-521.
111 +
Chuck SI, Sande MA.  Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med . 1989;;321:794-799.
112 +
Nelson MR, Smith DE, Shanson D, et al.  The limited value of routine serum antigen screening for cryptococcal infection.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract WBP17.
113 +
Minamoto G, Armstrong D.  Fungal infections in AIDS: histoplasmosis and coccidioidomycosis. Infect Dis Clin North Am . 1988;;2:447-456.
114 +
Galgiani JN, Ampel NM.  Coccidioidomycosis in human immunodeficiency virus-infected patients. J Infect Dis . 1990;;162:1165-1169.
115 +
Wheat LJ, Connolly-Stringfield PA, Baker RL, et al.  Disseminated histoplasmosis in the acquired immunodeficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine . 1990;;69:361-374.
116 +
Ampel NM, Dols CL, Galgiani JN.  Coccidioidomycosis during HIV infection: a continuing prospective study.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThB469.
117 +
Barnes PF, Bloch AB, Davidson PT, Snider DE.  Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med . 1991;; 324:1644-1650.
118 +
Selwyn PA, Hartel D, Lewis VA, et al.  A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med . 1989;;320:545-550.
119 +
Daley CL, Small PM, Schecter GF, et al.  An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus: an analysis using restriction-fragment-length polymorphisms. N Engl J Med . 1992;;326:231-235.
120 +
Centers for Disease Control.  Diagnosis and management of mycobacterial infection and disease in persons with human T-lymphotropic virus type-III lymphadenopathy-associated virus infection. MMWR . 1986;;35:448-452.
121 +
Centers for Disease Control.  Screening for tuberculosis and tuberculous infection in high-risk populations. MMWR . 1990;;39( (RR-8) ):1-7.
122 +
Graham NMH, Nelson KE, Solomon L, et al.  Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA . 1992;;267:369-373.
123 +
Huebner RE, Villarino ME, Snider DE.  Tuberculin skin testing and the HIV epidemic. JAMA . 1992;;267:409-410.
124 +
Centers for Disease Control.  Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR . 1991;;40( (RR-5) ):27-33.
125 +
Centers for Disease Control.  Protection against viral hepatitis: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR . 1990;;39( (RR-2) ):5-22.
126 +
Lebovic E, Dworkin BM, Heier SK, et al.  The hepatobiliary manifestations of human immunodeficiency virus infection. Am J Gastroenterol . 1988;; 83:1-7.
127 +
Griffin PM, Tauxe RV.  Food counseling for patients with AIDS. J Infect Dis . 1988;;158:668.
128 +
Janoff EN, Breiman RF, Daley CL, Hopewell PC.  Pneumococcal disease during HIV infection. Ann Intern Med . 1992;;117:314-324.
129 +
Centers for Disease Control.  Recommendations of the Immunization Practices Advisory Committee: pneumococcal polysaccharide vaccine. MMWR . 1989;;38:64-76.
130 +
Schlamm HT, Yancovitz SR.  Haemophilus influenzae pneumonia in young adults with AIDS, ARC, or risk of AIDS. Am J Med . 1989;;86:11-14.
131 +
Casadevall A, Dobroszycki J, Small C, Pirofski L.  Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS. Am J Med . 1992;;92:587-590.
132 +
Steinhoff MC, Auerbach BS, Nelson KE, et al.  Antibody responses to Haemophilus influenzae type b vaccines in men with human immunodeficiency virus infection. N Engl J Med . 1991;;325: 1837-1842.
133 +
Farley MM, Stephens DS, Brachman PS, et al.  Invasive Haemophilus influenzae disease in adults: a prospective, population-based surveillance. Ann Intern Med . 1992;;116:806-812.
134 +
Centers for Disease Control.  Increase in pneumonia mortality among young adults and the HIV epidemic: New York City, United States. MMWR . 1988;;37:593-596.
135 +
Selwyn PA, Feingold AR, Hartel D, et al.  Increased risk of bacterial pneumonia in HIV-infected intravenous drug users without acquired immunodeficiency syndrome. AIDS . 1988;;2:267-72.
136 +
Centers for Disease Control.  Prevention and control of influenza recommendations of the immunization practices advisory committee (ACIP). MMWR . 1992;;41( (RR-9) ):1-17.
137 +
Hadler SC, Judson FN, O'Malley PM, et al.  Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis . 1991;;163: 454-459.
138 +
Hadler SC.  Hepatitis b prevention and human immunodeficiency virus (HIV) infection. Ann Intern Med . 1988;;109:92-94.
139 +
Huang KL, Ruben FL, Rinaldo CR, et al.  Antibody responses after influenza and pneumococcal immunization in HIV-infected homosexual men. JAMA . 1987;;257:2047-2050.
140 +
Klein RS, Selwyn PA, Maude D, et al.  Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous dryg users infected with human immunodeficiency virus. J Infect Dis . 1989;;160:826-831.
141 +
Nelson KE, Clements ML, Miotti P, et al.  The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med . 1988;;109:383-388.
142 +
Ballet JJ, Sulcebe G, Couderc LJ, et al.  Impaired anti-pneumococcal antibody response in patients with AIDS related persistent generalized lymphadenopathy. Clin Exp Immunol . 1987;;68:479-487.
143 +
Ragni MV, Ruben FL, Winkelstein A, et al.  Antibody responses to immunization of patients with hemophilia with and without evidence of human immunodeficiency virus (human T-lymphotropic virus type III) infection. J Lab Clin Med . 1987;; 109:545-549.
144 +
Ochs HD, Junder AK, Collier AC, et al.  Abnormal antibody responses in patients with persistent generalized lymphadenopathy. J Clin Immunol . 1988;;8:57-63.
145 +
Janoff EN, Douglas JM, Gabriel M, et al.  Class-specific antibody response to pneumococcal capsular polysaccharide in men infected with human immunodeficiency virus type 1. J Infect Dis . 1988;; 158:983-990.
146 +
Collier AC, Corey L, Murphy VL, et al.  Antibody to human immunodeficiency virus and suboptimal response to hepatitis B vaccination. Ann Intern Med . 1988;;109:101-105.
147 +
Carne CA, Weller IVD, Waite J, et al.  Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. BMJ . 1987;;294:866-868.
148 +
Gesemann M, Scheiermann N, Brockmeyer N, et al.  Clinical evaluation of a recombinant hepatitis B vaccine in HIV-infected vs uninfected persons.  In: Zuckerman AJ, ed. Viral Hepatitis and Liver Disease . New York, NY: Alan R Liss; 1988;:1076-1078.
149 +
Loke RHT, Murray-Lyon IM, Coleman JC, et al.  Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor prognosis. J Med Virol . 1990;;31: 109-111.
150 +
Bruguera M, Cremades M, Salinas R, et al.  Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol . 1992;;14:27-30.
151 +
Opravil M, FIerz W, Matter L, et al.  Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients. Clin Exp Immunol . 1991;;84:185-189.
152 +
Miotti PG, Nelson KE, Dallabetta GA, et al.  The influence of HIV infection on antibody responses to a two-dose regimen of influenza vaccine. JAMA . 1989;;262:779-783.
153 +
Vardinon N, Handsher R, Burke M, et al.  Poliovirus vaccination responses in HIV-infected patients: correlation with T4 counts. J Infect Dis . 1990;;162:238-241.
154 +
Masur H, Michelis MA, Greene JB, et al.  An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction. N Engl J Med . 1981;;305:1431-1438.
155 +
Redfield RR, Wright DC, James WD, et al.  Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med . 1987;;316:673-676.
156 +
Centers for Disease Control.  Disseminated Mycobacterium bovis infection from BCG vaccination of a patient with acquired immunodeficiency syndrome. MMWR . 1986;;34:227-228.
157 +
Sprauer M, Markowitz L, Dales L, et al.  Evaluation of measles and rubella vaccination among HIV-infected adults.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThB542.
158 +
McLaughlin M, Thomas P, Onorato I, et al.  Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey. Pediatrics . 1988;;82:229-233.
159 +
Klein RS.  Prophylaxis of opportunistic infections in individuals infected with HIV. AIDS . 1989;; 3( (suppl 1) ):S161-S173.
160 +
Pinching AJ.  Editorial review: prophylactic and maintenance therapy for opportunistic infections in AIDS. AIDS . 1988;;2:335-343.
161 +
Greenspan JS, Greenspan D, Winkler JR.  Diagnosis and management of the oral manifestations of HIV infection and AIDS. Infect Dis Clin North Am . 1988;;2:387-396.
162 +
Gombert ME, duBouchet L, Aulicino TM, Butt KM.  A comparative trial of clotrimazole troches and oral nystatin suspension in recipients of renal transplants: use in prophylaxis of oropharyngeal candidiasis. JAMA . 1987;;258:2553-2555.
163 +
Leen CL, Dunbar EM, Ellis ME, et al.  Once-weekly fluconazole to prevent recurrence of oropharyngeal candidiasis in patients with AIDS and AIDS-related complex: a double-blind placebo-controlled study. J Infect . 1990;;21:55-60.
164 +
Stevens DA, Greene I, Lang OS.  Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome—related complex: randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch Intern Med . 1991;;151: 2458-2464.
165 +
Just-Nubling G, Gentschew G, Meissner K, et al.  Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Microbiol Infect Dis . 1991;;10:917-921.
166 +
Klein RS.  Prophylaxis of opportunistic infections in individuals infected with HIV. AIDS . 1989;; 3( (suppl 1) ):S161-S173.
167 +
Blasdon MJ, Tobin JM.  Recurrent vaginal candidiasis: prospective study of effectiveness of maintenance miconazole treatment. Genitourin Med . 1988;;64:124-127.
168 +
Roth AC, Milsom L, Forssman, Wahlen P.  Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet. Genitourin Med . 1990;;66:357-360.
169 +
Sobel JD.  Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med . 1986;;315:1455-1458.
170 +
Powderly WG, Saag MS, Cloud GA, et al.  A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med . 1992;;326:793-798.
171 +
Nightingale SD, Cal SX, Peterson DM, et al.  Primary prophylaxis with fluconazole against systemic fungal infections in HIV-positive patients. AIDS . 1992;;6:191-194.
172 +
Sprinz E, Matias K.  Cryptococcal meningitis prophylaxis with ketoconazole in patients with AIDS.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3261.
173 +
Castellano AR, Nettleman MD.  Cost and benefit of secondary prophylaxis for Pneumocystis carinii pneumonia. JAMA . 1991;;266:820-824.
174 +
Fischl MA, Dickinson GM, La Voie L.  Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA . 1988;;259:1185-1189.
175 +
MacGregor RR, Morgan AS, Graziani AL, et al.  Efficacy and tolerance of intermittent versus daily cotrimoxazole for PCP prophylaxis in HIV-positive patients. Am J Med . 1992;;92:227-229.
176 +
Hirschel B, Lazzarin A, Chopard P, et al.  A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia. N Engl J Med . 1991;;324:1079-1083.
177 +
Blum NR, Miller LA, Gaggin N, Cohn DL.  Comparative trial of dapsone versus trimethoprim/ sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. J Acquir Immune Defic Syndr . 1992;;5:341-347.
178 +
Kemper CA, Tucker RM, Lang OS, et al.  Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex. AIDS . 1990;;4:1145-1148.
179 +
Metroka CE, Jacobus D, Lewis N.  Successful chemoprophylaxis for Pneumocystis with dapsone or Bactrim.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract TBO4.
180 +
Carr A, Tindall B, Brew BJ, et al.  Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS. Ann Intern Med . 1992;;117:106-111.
181 +
Youle M.  Double blind, placebo controlled trial of high dose acyclovir for the prevention of cytomegalovirus (CMV) disease in late stage HIV disease.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract MoB0056.
182 +
Drew WL.  Herpes virus infection (infections caused by cytomegalovirus, herpes simplex virus, varicella-zoster virus): how to use gancyclovir (DHPG) and acyclovir. Infect Dis Clin North Am . 1988;;2:495-510.
183 +
Studies of Ocular Complications of AIDS Research Group, AIDS Clinical Trials Group.  Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med . 1992;;326:213-220.
184 +
Conant MA.  Prophylactic and suppressive treatment with acyclovir and the management of herpes in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol . 1988;;18:186-188.
185 +
Mindel A, Faherty A, Carney O, et al.  Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet . 1988;;1: 926-928.
186 +
Wadhawan D, Hira S, Mwansa N, et al.  Isoniazid prophylaxis among patients with HIV-1 infection.  In: Program and abstract of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThB510.
187 +
Centers for Disease Control.  The use of preventive therapy for tuberculous infection in the United States. MMWR . 1990;;39( (RR-8) ):9-12.
188 +
Chaisson RE, Slutkin G.  Tuberculosis and human immunodeficiency virus infection. J Infect Dis . 1989;;159:96-100.
189 +
Selwyn PA, Sckell BM, Alcabes P, Friedland GH, Klein RS, Schoenbaum EE.  High risk of active tuberculosis in HIV-infected drug users with cutaneous anergy. JAMA . 1992;;268:504-509.
190 +
Small PM, Schecter GF, Goodman PC, et al.  Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med . 1991;;324:289-294.
191 +
Gordin F, Nightingale S, Wynne B, et al.  Rifabutin monotherapy prevents or delays mycobacterium avium complex (MAC) bacteremia in patients with AIDS.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3081.
192 +
Cotton D, Weinberg D.  Survey results: treatment decisions in HIV care. AIDS Clin Care . 1992;; 4:85-91.
193 +
Carr A, Tindall B, Penny R, Cooper DA.  Trimethoprim-sulfamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS. AIDS . 1992;;6:165-171.
194 +
Martin MA, Cox PH, Beck K, et al.  A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch Intern Med . 1992;;152:523-528.
195 +
Mallolas J, Zamora L, Gatell JM, et al.  Low-dose co-trimoxazole, aerosolized pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia. Lancet . 1991;;337:1162-1163.
196 +
Torres RA, Barr M, Thorn M, et al.  Pneumocystis prophylaxis failures: a comparison of aerosolized pentamidine and dapsone.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3321.
197 +
Soloway B, Hecht F.  Changing approaches to PCP prophylaxis. AIDS Clin Care . 1992;;4:61-64.
198 +
Torres R, Thorn M, Barr M, et al.  Dapsone prophylaxis for toxoplasmosis and Pneumocystis carinii pneumonia.  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract WB2248.
199 +
Rich JD, Kazanjian PH, Hunter DJ, Maguire JH.  The effect of chemoprophylaxis for Pneumocystis carinii pneumonia (PCP) on development of reactivation toxoplasmosis.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3244.
200 +
Nielsen TL, Jensen BN, Mathiesen GJ, et al.  Secondary Pneumocystis prophylaxis (SPP): a prospective study with low dose sulfamethoxazole-trimethoprim (SMX-TMP) vs low dose aerosolized pentamidine (AP).  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract WB2224.
201 +
Heald A, Flepp M, Chave JP, et al.  Treatment for cerebral toxoplasmosis protects against Pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med . 1991;;115:760-763.
202 +
Kent RS. Data Concerning Pyrimethamine (Daraprim) . Letter to physicians from Burroughs Wellcome Co, Research Triangle Park, NC, August 10, 1992;.
203 +
Fischl MA, Richman DD, Grieco MH, et al.  The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N Engl J Med . 1987;;317:185-191.
204 +
Volberding PA, Lagakos SW, Koch MA, et al.  Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med . 1990;;322:941-949.
205 +
Fischl MA, Richman DD, Hansen N, et al.  The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Ann Intern Med . 1990;;112:727-737.
206 +
Hamilton JD, Hartigan PM, Simberkoff MS, et al.  A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection: results of the Veterans Affairs Cooperative Study. N Engl J Med . 1992;;326:437-443.
207 +
Graham NMH, Zeger SL, Park LP, et al.  The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med . 1992;;326:1037-1042.
208 +
McLeod GX, Hammer SM.  Zidovudine: five years later. Ann Intern Med . 1992;;117:487-501.
209 +
Corey L, Fleming TR.  Treatment of HIV infection: progress in perspective. N Engl J Med . 1992;;326:484-485.
210 +
 Zidovudine for symptomless HIV infection. Lancet . 1990;;335:821-822. Editorial.
211 +
Ruedy J, Schechter M, Montaner JSG.  Zidovudine for early human immunodeficiency virus (HIV) infection: who, when, and how? Ann Intern Med . 1990;;112:721-723.
212 +
Gazzard BG.  When should asymptomatic patients with HIV infection be treated with zidovudine? BMJ . 1992;;304:456-457.
213 +
Kahn JO, Lagakos SW, Richman DD, et al.  A controlled trial comparing continued zidovudine with didanosine in human immunodeficiency virus infection. N Engl J Med . 1992;;327:581-587.
214 +
Groopman JE, Molina JM.  Nucleoside therapy for HIV infection: some answers, many questions. N Engl J Med . 1992;;327:639-641.
215 +
Abrams DI, Grieco MH, eds. AIDS/HIV Treatment Directory . Washington, DC: American Foundation for AIDS Research; 1991;.
216 +
Sachs MK.  Antiretroviral chemotherapy of human immunodeficiency virus infections other than with azidothymidine. Arch Intern Med . 1992;;152: 485-501.
217 +
Cohen M.  Chinese medicine in the treatment of chronic immunodeficiency: diagnosis and treatment. Am J Acupunct . 1990;;18:111-122.
218 +
Moseson M, Zeleniuch-Jacquotte A, Belsito DY, et al.  The potential role of nutritional factors in the induction of immunologic abnormalities in HIV-positive homosexual men. J Acquir Immune Defic Syndr . 1989;;2:235-247.
219 +
Schlenzig C, Rieder JH, Hammel G, Popescu M.  Supervised physical exercise leads to psychological and immunological improvement in pre-AIDS patients.  In: Program and abstracts of the Fifth International Conference on AIDS ; June 4-9, 1989;; Montreal, Quebec. Abstract TBP301.
220 +
Royce RA, Winkelstein W.  HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study. AIDS . 1990;;4:327-333.
221 +
Becker MH, Brooks-Gunn J, Coates TJ, et al.  Facilitating change in health behaviors.  In: Miller HG, ed. AIDS: Sexual Behavior and Intravenous Drug Use . Washington, DC: National Academy Press; 1989;:259-315.
222 +
Kotler DP.  Nutritional support in AIDS. Am J Gastroenterol . 1991;;86:539-541.
223 +
 Nutrition and HIV. Lancet . 1991;;338:86-87. Editorial.
224 +
Heckler LM, Kotler DP.  Malnutrition in patients with AIDS. Nutr Rev . 1990;;48:393-401.
225 +
Laperriere AR, Antoni MH, Schneiderman N, et al.  Exercise intervention attenuates emotional distress and natural killer cell decrements following notification of positive serologic status for HIV-1. Biofeedback Self Regul . 1990;;15:229-242.
226 +
Schlenzig C, Jaeger H, Wehrenberg M, et al.  Physical exercise favorably influences the course of illness in patients with HIV and AIDS.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3401.
227 +
Buskin SE, Hopkins SG, Farizo KM.  Heavy smoking increases the risk of Pneumocystis carinii pneumonia (PCP).  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract WeC1030.
228 +
Nieman R, Fleming J, Coker RJ, et al.  Cigarette smoking by HIV infected individuals is associated with a more rapid progression to AIDS.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoC4407.
229 +
Weber R, Ledergerber B, Opravil M, et al.  Progression of HIV infection in misusers of injected drugs who stop injecting or follow a program of maintenance treatment with methadone. BMJ . 1990;; 301:1362-1365.
230 +
Seber R, Ledergerber B, Opravil M, et al.  Cessation of intravenous drug use reduces progression of HIV-infection in HIV+ drug users.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract ThC36.
231 +
Kaslow RA, Blackwelder WC, Ostrow DG, et al.  No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1—positive individuals: a report from the Multicenter AIDS Cohort Study. JAMA . 1989;;261: 3424-3429.
232 +
Brown LS, Siddiqui N.  Relationship between cocaine use and HIV disease progression in injecting drug users (IDUs).  In: Program and abstracts of the Seventh International Conference on AIDS ; June 16-21, 1991;; Florence, Italy. Abstract MC3156.
233 +
Feldman DA, ed. Culture and AIDS . New York, NY: Praeger Publishers; 1990;.
234 +
Wolcott DL.  Psychosocial aspects of acquired immune deficiency syndrome and the primary care physician. Ann Allergy . 1986;;57:95-102.
235 +
Holland JC, Tross S.  The psychosocial and neuropsychiatric sequelae of the acquired immunodeficiency syndrome and related disorders. Ann Intern Med . 1985;;103:760-764.
236 +
Dew MA, Ragni MV, Nimorwicz P.  Infection with human immunodeficiency virus and vulnerability to psychiatric distress: a study of men with hemophilia. Arch Gen Psychiatry . 1990;;47:737-744.
237 +
Perry SW, Markowitz J.  Psychiatric interventions for AIDS-spectrum disorders. Hosp Community Psychiatry . 1987;;37:1001-1006.
238 +
Kelly JA, St Lawrence JS. The AIDS Health Crisis: Psychological and Social Interventions . New York, NY: Plenum Press; 1988;.
239 +
Katoff L, Dunne R.  Supporting people with AIDS: the Gay Men's Health Crisis model. J Palliat Care . 1988;;4:88-95.
240 +
Perry S, Fishman B, Jacobsberg L, et al.  Effectiveness of psychoeducational interventions in reducing emotional distress after human immunodeficiency virus antibody testing. Arch Gen Psychiatry . 1991;;48:143-147.
241 +
Kelly PJ.  Evaluation of a meditation and hypnosis-based stress management program for men with HIV.  In: Program and abstracts of the Sixth International Conference on AIDS ; June 19-23, 1990;; San Francisco, Calif. Abstract WDP17.
242 +
Zich J, Temoshok L.  Perceptions of social support, distress and hopelessness in men with AIDS and ARC: clinical implications.  In: Temoshok L, Baum A, eds. Psychosocial Perspectives on AIDS: Etiology, Prevention, and Treatment . Hillsdale, NJ: Lawrence Erlbaum Associates Inc; 1990;:201-227.
243 +
Gremmen T, VanDemboom FMLG, Witlox R.  Self help groups for PWAs show positive results.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3802.
244 +
Mulder C, Emmelkamp PMG, Mulder JW, et al.  Immunological and psychosocial effects of a cognitive-behavioral vs an experiential group therapy program for asymptomatic HIV seropositive homosexual men.  In: Program and abstracts of the Eighth International Conference on AIDS/III STD World Congress ; July 19-24, 1992;; Amsterdam, the Netherlands. Abstract PoB3809.

Letters

Submit a Letter
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2012 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems